Mammography is a non-invasive medical diagnostic procedure that is used for the screening of breast tissues for cancerous cells. A mammography exam, or mammogram, uses analog, digital, computer-aided detection, and tomosynthesis systems to highlight small tumors, cysts, and other irregularities in the breasts. The mammography market is expected to grow tremendously in the coming years due to the surge in the incidences of breast cancer and rising awareness among the population regarding the benefits of early diagnosis of cancer. According to the American Cancer Society, in 2021, 281,550 new cases of breast cancer are estimated to be diagnosed, and around 49,290 related deaths are expected to occur in the U.S. alone. As per the World Health Organization (WHO), in 2021, breast cancer is the most common type of cancer at a global level, with new cases surpassing 2.3 million.
๐๐จ ๐๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐๐ฎ๐ฅ ๐๐๐ฌ๐๐๐ซ๐๐ก, ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ ๐๐จ๐ฉ๐ฒ - https://univdatos.com/get-a-free-sample-form-php/?product_id=34885
The Mammography Market is expected to grow at a steady rate of around 8% during the forecast period (2022-2028). The mammography market is growing at high rates due to the rise in the geriatric population, the surge in the prevalence of breast cancer. For instance, breast cancer is 1.7 times more common in women over 65 than in women 45 to 64 years old, and 10 times more common in women under 45. Similarly, as per a research article published in the NCBI, breast cancer incidence rises with age, from 1.5 occurrences per 100,000 in women 20 to 24 years old to 421.3 cases per 100,000 in women 75 to 79 years old, with 95% of new cases occurring in women aged 40 and above. Apart from this, the rising government initiatives to promote breast cancer awareness is also having a positive impact on the market’s growth. For example, in October 2021, the Goa government launched ‘'Swasth Mahila, Swasth Goa’, an initiative for free breast cancer screening for 1 lakh women. In November 2021, Greater Chennai Corporation launched initiatives to raise awareness regarding breast cancer.
According to UnivDatos Market Insights (UMI)’ research report “Global Mammography Market”, the market is expected to witness robust growth during the forecast period (2022-2028) owing to technological advancements and an increase in investment by pharmaceutical giants. The key players are rapidly launching novel products, which are also having a positive impact on market growth. For instance, in October 2022, PDC launched Comfort Cushion Mammography Pad for use by mammography providers, including hospitals and breast and women's health centers. The cushy pad is applied by mammography technicians to the receptor plate of the mammography machine to reduce patient discomfort during compression. Moreover, in December 2021, GE advanced a mammographic platform that offered 3D technology utilizing the same low radiation that traditional 2D technology does.
๐๐จ ๐๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐๐ฎ๐ฅ ๐๐๐ฌ๐๐๐ซ๐๐ก, ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ ๐๐จ๐ฉ๐ฒ - https://univdatos.com/get-a-free-sample-form-php/?product_id=34885
Based on product, the market is segmented into film screen systems, digital systems, analog systems, and 3D systems. The digital systems held a dominant share of the market in 2020 due to their superior depiction of low-contrast objects, wider dynamic change, and enhanced diagnostic quality of images, especially when examining denser breasts. Moreover, a wide range of product availability is also boosting the demand for digital systems. For instance, in August 2021, FUJIFILM Medical Systems Inc. launched ScreenPoint Medical’s, FDA cleared Transpara powered by Fusion artificial intelligence (AI) for 2D and 3D mammography in the U.S. In addition, in April 2021, Fujifilm GmbH launched the “Harmony” version of its Amulet Innovality mammography system in Germany. AMULET Innovality is a Full Field Digital Mammography (FFDM) equipped with Fujifilm’s unique and innovative technologies that achieve optimum image quality at a very low patient dose.
Based on the technology outlook, technology outlook, the market is categorized into breast tomosynthesis, CAD mammography, and digital mammography. Digital mammography held a significant share of the market in 2020. It is a specialized and sophisticated form of mammography which evaluates breast tissues for the presence of cancers by utilizing digital sensors and computers rather than X-ray films. Full field digital mammography is one of the commonly used ditial mammography. It has the potential to make significant advancements in the detection of breast cancer, such as lowered radiation doses, minimizing breast compression pressure, and thus enhancing detection. Thus, these factors are driving the segmental growth.
Based on end-use, the market is segmented into hospitals, speciality clinics, diagnostic centers, ambulatory surgical centers, and educational & research institutes. The diagnostic center is anticipated to witness high CAGR during the forthcoming years, attributed to rise in awareness about breast cancer diagnosis among individuals. This has boosted the demand for mammography procedures used for diagnosis, therapy planning, and prevention of breast cancer. The availability of advanced mammography services in diagnostic centers of developed & developing economies, such as the U.S., Germany, the U.K., Japan, China, and India, is expected to propel the overall segment growth.
For More Informative Information, Please Visit Us – https://univdatos.com/report/mammography-market/
APAC to witness extensive growth
For a better understanding of the market adoption of the mammographyindustry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is anticipated to grow at a substantial CAGR during the forecast period attributed to the rise in the incidences of breast cancer, high research and development activities, and novel product launches. According to the GLOBOCAN 2020 database, around 92,024 new breast cancer cases were diagnosed that accounting for 8.9% of all cancer cases in Japan. This significant disease prevalence is set to proliferate business growth in the near future. Moreover, rising government initiatives to increase awareness among individuals will also have a positive impact on the market’s growth. For instance, the Breast Health Global Initiative (BHGI), an alliance of public & private organizations issues supportive guidelines for early detection and therapeutics of breast cancer in low- and middle-income countries in Asia to improve awareness and clinical outcomes. Furthermore, some countries in the region such as South Korea, Japan, Singapore, and Taiwan among others have started population-based screening campaigns.
According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the mammography market are Hologic, Inc.; CANON MEDICAL SYSTEMS CORPORATION; Siemens Healthcare GmbH; Koninklijke Philips NV; FUJIFILM Holdings Corporation; GE HealthCare; Metaltronica S.p.A; PLANMED OY; Carestream Health; and Analogic Corporation.
“Global Mammography Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on different parameters. This will help companies in the formulation of go-to-market strategies and identifying the blue ocean for its offerings.
Market Segmentation:
1. By Product (Film Screen Systems, Digital Systems, Analog Systems, and 3D Systems)
2. By Technology Outlook (Breast Tomosynthesis, Cad Mammography, and Digital Mammography)
3. By Modality (Portable and Non-Portable)
4. By End-Use (Hospitals, Speciality Clinics, Diagnostic Centers, Ambulatory Surgical Centers, and Educational & Research Institutes)
5. By Region (North America, Europe, Asia-Pacific, Rest of the World)
6. By Company (Hologic, Inc.; CANON MEDICAL SYSTEMS CORPORATION; Siemens Healthcare GmbH; Koninklijke Philips NV; FUJIFILM Holdings Corporation; GE HealthCare; Metaltronica S.p.A; PLANMED OY; Carestream Health; and Analogic Corporation)
Key questions answered in the study:
1. What are the current and future trends of the global mammography industry?
2. How the industry has been evolving in terms of product, technology outlook, modality, and end-use?
3. How the competition has been shaping across the countries followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the global mammography industry?
5. What is the customer orientation, purchase behavior, and expectations from the global mammography suppliers across various region and countries?
Table of Content:-
1 MARKET INTRODUCTION
2 RESEARCH METHODOLOGY OR ASSUMPTION
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 IMPACT OF COVID-19 ON THE MAMMOGRAPHY MARKET
6 MAMMOGRAPHY MARKET REVENUE (USD BN), 2020-2028F
7 MARKET INSIGHTS BY PRODUCT
8 MARKET INSIGHTS BY TECHNOLOGY OUTLOOK
9 MARKET INSIGHTS BY MODALITY
10 MARKET INSIGHTS BY END-USE
11 MARKET INSIGHTS BY REGION
12 MAMMOGRAPHY MARKET DYNAMICS
13 MAMMOGRAPHY MARKET OPPORTUNITIES
14 MAMMOGRAPHY MARKET TRENDS
15 DEMAND AND SUPPLY-SIDE ANALYSIS
16 VALUE CHAIN ANALYSIS
17 COMPETITIVE SCENARIO
18 COMPANY PROFILED
19 DISCLAIMER